Download PDF
Exp Clin Endocrinol Diabetes 2023; 131(07/08): 383-385
DOI: 10.1055/a-2129-3672
Editorial

Progress in Primary Aldosteronism 7: No better time to meet!

Martin Reincke
1   Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany
,
William E. Rainey
2   Division of Metabolism, Endocrinology, and Diabetes, University of Michigan, Ann Arbor, Michigan
,
Tracy Ann Williams
1   Medizinische Klinik und Poliklinik IV, Klinikum der Universität, Ludwig-Maximilians-Universität München, Germany
› Author Affiliations Funding We acknowledge the generous support of the Carl Friedrich von Siemens Stiftung and of the Deutsche Forschungsgemeinschaft (CRC/TRR 205 “The adrenal gland: Central relay in health and disease”) in funding the Progress in Primary Aldosteronism symposium. The authors of this editorial are supported by the Else Kröner-Fresenius Stiftung (German Conn’s Registry-Else-Kröner Hyperaldosteronism Registry; 2013_A182 and 2015_A171 to M.R.), the Deutsche Forschungsgemeinschaft (CRC/TRR 205/1 “The adrenal gland: Central relay in health and disease” to T.A.W. and M.R.), by the European Research Council (grant number 694913 [PAPA] to M.R.).
› Further Information
Also available at
   Permissions and Reprints

Key words

aldosterone - renin - adrenal adenoma - secondary hypertension - endocrine hypertension


Publication History

Article published online:
11 August 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Riccaboni M, Verginer L. The impact of the COVID-19 pandemic on scientific research in the life sciences. PLoS One 2022; 17: e0263001 DOI: 10.1371/journal.pone.0263001.. eCollection 2022.
    CrossrefPubMedGoogle Scholar
  • 2 Scholl UI, Stölting G, Schewe J et al. CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nat Genet 2018; 50: 349–354. 10.1038/s41588-018-0048-5. Epub 2018 Feb 5.
    PubMed
  • 3 Fernandes-Rosa FL, Daniil G, Orozco IJ et al. A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet. 2018; 50: 355–361. 10.1038/s41588-018-0053-8. Epub 2018 Feb 5. PMID: 29403012 Free article.
    PubMed
  • 4 Zhou J, Azizan EAB, Cabrera CP et al. Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause. Nat Genet. 2021; 53: 1360–1372. 10.1038/s41588-021-00906-y. Epub 2021 Aug 12. PMID: 34385710 Free PMC article.
    PubMed
  • 5 Le Floch E, Cosentino T, Larsen CK et al. Identification of risk loci for primary aldosteronism in genome-wide association studies. Nat Commun. 2022; 13: 5198. 10.1038/s41467-022-32896-8. PMID: 36057693 Free PMC article.
    PubMed
  • 6 Naito T, Inoue K, Sonehara K et al. Genetic risk of primary aldosteronism and Its contribution to hypertension: a cross-ancestry meta-analysis of genome-wide association studies. Circulation. 2023; 147: 1097-1109. 10.1161/CIRCULATIONAHA.122.062349. Epub 2023 Feb 21. PMID: 36802911 Free PMC article.
    PubMed
  • 7 Wu X, Azizan EAB, Goodchild E et al. Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production. Nat Genet. 2023; 55: 1009–1021. 10.1038/s41588-023-01403-0. Epub 2023 Jun 8. PMID: 37291193 Free PMC article.
    PubMed
  • 8 Brown JM, Siddiqui M, Calhoun DA et al. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020; 173: 10–20. 10.7326/M20-0065. Epub 2020 May 26. PMID: 32449886 Free PMC article.
    PubMed
  • 9 Eisenhofer G, Kurlbaum M, Peitzsch M et al. The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy. J Clin Endocrinol Metab. 2022; 107: e2027–e2036. 10.1210/clinem/dgab924. PMID: 34963138 Free PMC article.
    PubMed
  • 10 Nanba K, Omata K, Gomez-Sanchez CE et al. Genetic characteristics of aldosterone-producing adenomas in blacks. Hypertension. 2019; 73: 885–892. 10.1161/HYPERTENSIONAHA.118.12070. PMID: 30739536 Free PMC article.
    PubMed
  • 11 Taylor MJ, Ullenbruch MR, Frucci EC. et al. Chemogenetic activation of adrenocortical Gq signaling causes hyperaldosteronism and disrupts functional zonation. J Clin Invest 2020; 130: 83-93 DOI: 10.1172/JCI127429.
    CrossrefPubMedGoogle Scholar
  • 12 Wannachalee T, Caoili E, Nanba K et al. The concordance between imaging and adrenal vein sampling varies with aldosterone-driver somatic mutation. J Clin Endocrinol Metab. 2020; 105: e3628–e3637. 10.1210/clinem/dgaa482. PMID: 32717082 Free PMC article.
    PubMed
  • 13 Gong S, Sun N, Meyer LS et al. Primary aldosteronism: spatial multiomics mapping of Genotype-Dependent Heterogeneity and Tumor Expansion of Aldosterone-Producing gdenomas. Hypertension. 2023; 80: 1555–1567. 10.1161/HYPERTENSIONAHA.123.20921. Epub 2023 May 1. PMID: 37125608
    PubMed
  • 14 Nanba K, Baker JE, Blinder AR et al. Histopathology and genetic causes of primary aldosteronism in young adults. J Clin Endocrinol Metab 2022; 107: 2473–2482. 10.1210/clinem/dgac408. PMID: 35779252 Free PMC article.
    PubMed
  • 15 Turcu AF, Yang J, Vaidya A Primary aldosteronism – a multidimensional syndrome. Nat Rev Endocrinol 2022; 18: 665–682. 10.1038/s41574-022-00730-2. Epub 2022 Aug 31. PMID: 36045149 Review.
    PubMed
  • 16 Wu X, Senanayake R, Goodchild E et al. [11C]Metomidate PET-CT versus adrenal vein sampling for diagnosing surgically curable primary aldosteronism: a prospective, within-patient trial. Nat Med. 2023; 29: 190–202. 10.1038/s41591-022-02114-5. Epub 2023 Jan 16.
    PubMed
  • 17 Williams TA, Gomez-Sanchez CE, Rainey WE et al. International histopathology consensus for unilateral primary aldosteronism. J Clin Endocrinol Metab. 2021; 106: 42–54. 10.1210/clinem/dgaa484. PMID: 32717746 Free PMC article.
    PubMed
  • 18 Williams TA, Gong S, Tsurutani Y et al. Adrenal surgery for bilateral primary aldosteronism: an international retrospective cohort study. Lancet Diabetes Endocrinol. 2022; 10: 769–771. 10.1016/S2213-8587(22)00253-4. Epub 2022 Sep 19.
    PubMed
  • 19 Gomez-Sanchez CE, Gomez-Sanchez EP. An abbreviated history of aldosterone metabolism: current and future challenges. Exp Clin Endocrinol Diabetes 2023; DOI: 10.1055/a-2054-1062.. Online ahead of print. PMID: 36918165
    CrossrefPubMedGoogle Scholar
  • 20 Charoensri S, Turcu AF. Primary aldosteronism prevalence – an unfolding story. Exp Clin Endocrinol Diabetes 2023; DOI: 10.1055/a-2066-2696.. Online ahead of print. PMID: 36996879
    CrossrefPubMedGoogle Scholar
  • 21 Libianto R, Stowasser M, Russell G et al. Improving detection rates for primary aldosteronism. Exp Clin Endocrinol Diabetes. 2023. 10.1055/a-2048-6213. Online ahead of print. PMID: 37160153
    PubMed
  • 22 Lenzini L, Pintus G, Rossitto G et al. Primary aldosteronism and drug resistant hypertension: a "chicken-egg" story. Exp Clin Endocrinol Diabetes. 2023. 10.1055/a-2073-3202. Online ahead of print. PMID: 37054985
    PubMed
  • 23 Younes N, Larose S, Bourdeau I. et al. Role of adrenal vein sampling in guiding surgical decision in primary aldosteronism. Exp Clin Endocrinol Diabetes 2023; 131: 418–434.
    PubMed
  • 24 Gkaniatsa E, Ragnarsson O. Adrenal vein sampling in the young - necessary or not?. Exp Clin Endocrinol Diabetes 2023; 131: 435–437 DOI: 10.1055/a-2099-3525.. Online ahead of print . PMID: 37225137
    CrossrefPubMedGoogle Scholar
  • 25 Lee YN, Drake WM. Radiofrequency ablation in primary aldosteronism. Exp Clin Endocrinol Diabetes 2023; 131: 438–442.
    PubMed